×
ADVERTISEMENT

sunvozertinib

FDA Grants Accelerated Approval to Zegfrovy for Some Patients With Metastatic NSCLC

The FDA granted accelerated approval to sunvozertinib (Zegfrovy, Dizal [Jiangsu] Pharmaceutical) for adult patients ...

JULY 2, 2025

Load more